CPT® Code 80348

The CPT® Code 80348 refers to a laboratory test specifically designed to measure the levels of buprenorphine and its metabolites in biological samples such as urine, serum, or plasma. Buprenorphine is classified as a semi-synthetic opioid partial agonist, which means it activates opioid receptors in the brain but to a lesser degree than full agonists. This property makes it particularly useful in the treatment of opioid addiction, as it can help manage withdrawal symptoms and cravings without producing the same level of euphoria associated with stronger opioids. Additionally, buprenorphine is utilized for controlling acute or chronic pain in individuals who are not tolerant to opioids. The medication is available in various formulations, including oral tablets (such as Subutex, Suboxone, and Zubsolv) for the treatment of opioid dependence, and sublingual preparations (like Temgesic) for managing moderate to severe pain. For acute pain management, buprenorphine can be administered via injection (Buprenex), while chronic pain may be treated with transdermal patches (Norspan, Butrans) that deliver the drug through the skin over an extended period. To perform the test, a blood sample is typically obtained through venipuncture, which is a separately reportable procedure. Urine samples can be collected either by random voiding or through catheterization. The testing process involves advanced techniques such as quantitative high-performance liquid chromatography-tandem mass spectrometry for serum or plasma samples, and quantitative liquid chromatography-tandem mass spectrometry for urine samples. These methods ensure accurate measurement of buprenorphine levels, which is essential for monitoring treatment efficacy and compliance in patients undergoing therapy for opioid addiction or pain management.